Furthermore, this activation of Notch2 by ECs-derived Dll4 is essential for the progression of muscle atrophy seen in these pathologies, suggesting that this secreted Dll4 may be a potential therapeutic target for disuse muscle and diabetes-induced muscle atrophy (Fujimaki et al., 2022). The gene discussed is NOTCH2; the disease is diabetes mellitus.